https://www.bloomberg.com/authors/ARchMYxXWEk/richard-g-frank RSS for Node Sun, 17 May 2026 05:46:37 GMT https://www.bloomberg.com/opinion/articles/2023-09-05/medicare-negotiations-won-t-keep-big-pharma-from-making-a-fortune https://www.bloomberg.com/opinion/articles/2023-09-05/medicare-negotiations-won-t-keep-big-pharma-from-making-a-fortune Tue, 05 Sep 2023 12:00:04 GMT CHICAGO, ILLINOIS - AUGUST 29: In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. (Photo Illustration by Scott Olson/Getty Images)